ESCRS - POREF133 - Visual Acuity Gain And Functional Neuroadaptation Following Posterior Chamber Phakic Iol Implantation In Adult Refractive Amblyopia

Visual Acuity Gain And Functional Neuroadaptation Following Posterior Chamber Phakic Iol Implantation In Adult Refractive Amblyopia

Published 2026 - 44th Congress of the ESCRS

Reference: POREF133 | Type: Free paper | DOI: 10.82333/tvc8-nh60

Authors: Dr Safaa Jihad* 1 , Mr Maulik Ganatara 2 , Mr Katre Nada el bakkouti El bakkouri 3

1Scientific commitee,MEOM ,Dubai ,United Arab Emirates, 2Product management ,Biotech healthcare,Ahmedabad,India, 3Product management ,Biotech healthcare,Rabat,Morocco

Purpose

To evaluate visual acuity outcomes and functional neuroadaptation following posterior chamber phakic IOL implantation in adults with refractive amblyopia—an uncommon and non-standard indication for refractive lens correction.

Setting

Single-center interventional case series, Casablanca, Morocco.

Methods

Eight adult patients (14 eyes) with refractive amblyopia and significant anisometropia underwent implantation with Eyecryl Phakic or Eyecryl Phakic Toric IOLs. Preoperative and postoperative assessments included uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), manifest refraction, vault measurement, rotational stability, intraocular pressure (IOP), and endothelial cell density (ECD). Line gain and binocular functional improvement were analyzed over 3–24 months of follow-up.

Results

Preoperative BCVA ranged from 0.5/10 to 7/10. Postoperatively, UCVA improved to 7–10/10 in most eyes. A gain of 1–2 Snellen lines was observed in the majority of amblyopic eyes, with marked improvement in severe anisometropic cases. No eye lost BCVA. Residual refractive error was generally within ±0.75 D.

Mean 1-month vault was approximately 470 µm (range 420–510 µm), remaining stable over time. Toric rotation was <5°, IOP remained clinically stable, and ECD loss was <3%.

in all cases, the postoperative visual acuity—whether immediate or medium to long term—was significantly superior to the best corrected visual acuity before the phakic implant.

Conclusions

Although amblyopia is not a conventional indication for pIOL implantation, posterior chamber phakic IOLs demonstrated meaningful visual gain and stable anatomical outcomes in selected cases. Reduction of anisometropia may promote postoperative neuroadaptation and expand the clinical versatility of phakic IOL technology.